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ABSTRACT
Cardiovascular diseases (CVDs) are leading health problems caused by several risk
factors, which include obesity. Obesity is defined as abnormal or excessive fat
accumulation that may impair health and is the fifth leading risk for global deaths.
Wet cupping therapy (WCT) is a recognized Malay traditional medicine that was
shown pre-clinically to be effective against CVD parameters. This study was
conducted to determine effects ofWCT on blood parameters and quality of life (QoL)
of obese male individuals at baseline, pre- and post-WCT sessions and to look for
differences between venous and cupping bloods samples. Obese male participants
aged 22 until 39 years old were recruited with informed consent to receive two WCT
sessions. Blood was collected via venipuncture from all participants at baseline, pre-
and post-WCT sessions. Wet cupping sessions were conducted on days 28th and 35th.
Venous and cupping blood samples were collected and analyzed. Study participants
answer questionnaires related to quality of life. There were significant increase in
aspartate transaminase (p < 0.05) and significant decrease in total protein (p < 0.001)
between baseline, pre- and post-WCT sessions. Hematological parameters remained
unchanged after WCT. Metabolite pathways via log fold change analysis uncovered
insignificant regulation between baseline - pre-cupping venous bloods (p > 0.05),
significant down regulation between pre-cupping - post-cupping (p < 0.001), and
significant metabolites up regulation in cupping as compared to venous blood ( p ~
0.001), including linoleic acid (LA), sphingosine I-phosphate (SIP) and
glycochenodeoxycholate (GCDC). Three cupping points ofWCT were found to affect
several blood parameters and metabolic pathways associated with CVD. This findings
provide evidence that WCT may be utilized as adjuvant treatment management
against CVDs and obesity.
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CHAPTER ONE
INTRODUCTION
1.1 Research Background
Cardiovascular diseases (CVDs), including heart diseases and vascular
diseases, are most critical global health threats, contributing to more than one-third of
the mortality and morbidity worldwide (Deaton et. al., 2011). In most cases, these
clinical conditions result from atherosclerosis, which was once identified as a lipid-
storage disease (Rocha & Libby, 2009). Now, CVD is recognized as a chronic
inflammatory condition of the vessel wall that results from the transendothelial
passage (transcytosis) of cholesterol-rich atherogenic Apo-B lipoproteins (VLDL, IOL
and LDL) from the plasma into the intima. Smoking, obesity, hypertension, diabetes,
physical inactivity and hypercholesterolemia are established risk factors of CVD
(Zhaoxia Wang & Nakayama, 2010). Among these factors, obesity is currently
identified as the main factor being associated with cardiovascular disease (Sowers,
2003).
Obesity and overweight are defined as abnormal or excessive fat accumulation
that may impair health and are the fifth leading risk for global deaths (World Health
Organization, 2013). Sources of fat deposition come from high-fat diet intakes or from
immoderate sugar consumption (De Wit et. al., 2012). Current national nutrition and
health surveys reveal that Malaysians are affected by western health problems
(Nazaimoon et. al., 2011), while there is a paradigm shift in western nations where
sugar is regarded as an independent risk factor for CVD (Schmidt, 2014). The
escalation of obesity, once thought to be an urban phenomenon, has now spread to the
rural population at an alarming rate (Ismail, Chee, & Nawawi, 2002). The prevalence
of overweight among Malaysian adults has increased almost two fold from 16.6% to
29.7% in 2009 (Azmi et. aI., 2009) while the prevalence of obesity increased from
12.2% in 2003 to 15.1% in 2011 (Jan Mohamed et. al., 2015).
The ongoing conventional therapy for obesity is bariatric surgery, containing
Roux-en-Y gastric bypass, sleeve gastrectomy, duodenal switch, and employment of
an adjustable gastric band. Bariatric surgery can cause severe short and long-term
drawbacks. Researchers have been developing pharmacotherapies and minimally
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